JBM (Healthcare) Limited (SEHK: 2161)
Health Care · Pharmaceuticals · HK
HK$1.63
+1.88% today · -46.2% 1Y
JBM (Healthcare) Limited (SEHK: 2161) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $169.76M and employs 404 people.
Over the last twelve months the share price has lost 46.2%, trading between 1.58 and 3.11.
Tweenvest scores JBM (Healthcare) Limited across four factors: quality 79/100, value 72/100, growth 86/100, dividend 91/100. Its strongest factor is dividend.
2161 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $169.76M
- Revenue (TTM)
- $106.46M
- P/E
- 6.60
- EPS
- 0.25
- Dividend yield
- 10.72%
- Beta (5Y)
- 0.23
- 52-week high
- HK$3.11
- 52-week low
- HK$1.58
- Avg volume (3M)
- —
- Shares outstanding
- 819.80M
- Employees
- 404
- Next earnings
- —
About JBM (Healthcare) Limited
JBM (Healthcare) Limited functions as an investment holding company that operates across Asia, engaging in the entire process of bringing healthcare and wellness products to market, from their conception and production to their promotion, distribution, and ultimate sale. The firm's offerings include a diverse range of consumer health products, such as its own branded traditional Chinese medicines – spanning everything from over-the-counter medications to specific medicated and non-medicated treatments. Additionally, it supplies diagnostic equipment and various pharmaceutical goods. Beyond manufacturing, JBM (Healthcare) is also involved in the buying, selling, and reselling (wholesale and retail) of Chinese medicines. Its business activities extend to the trade of medical supplies and pharmaceuticals, as well as the sale of general health and herbal products. Established in 2020, the company's main operations are directed from its headquarters in Kwun Tong, Hong Kong. JBM (Healthcare) Limited is a subsidiary entity of JBM Group (BVI) Limited.
- ISIN
- KYG1090B1077
- Founded
- 2020
- Listed since
- Feb 5, 2021
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Highnoon Laboratories LimitedKASE: HINOON | $177.77M | PKRs929.10 | +0.01% |
| IT-Chem CO.,LtdKOSDAQ: A309710 | $173.78M | ₩— | — |
| Jilin Province Huinan Changlong Bio-pharmacy Company LimitedSEHK: 8049 | $172.77M | HK$2.42 | +4.09% |
| Kahira Pharmaceuticals & Chemical Industries CompanyCASE: CPCI | $171.93M | EGP602.90 | +1.21% |
| Binh Dinh Pharmaceutical and Medical Equipment Joint Stock CompanyHOSE: DBD | $169.19M | ₫46,350.00 | -0.86% |
| Mecure Industries PLCNGSE: MECURE | $169.05M | ₦56.20 | -9.94% |
| AN2 Therapeutics, Inc.NasdaqGS: ANTX | $166.04M | $4.30 | -2.27% |
| The Searle Company LimitedKASE: SEARL | $165.39M | PKRs77.86 | -1.36% |
Figures last refreshed Oct 11, 2026.